Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Advancing Cardiac Care: AI in Aortic Stenosis Management
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
The Relevance of AI in Mastering Polypharmacy Management
Advancing Healthcare: The Role of Real-World Evidence in Decision-Making
Innovative Technology Policy: Simulation Modelling in Healthcare
Innovations in Surgery: Clinical and Economic Implications
Economic Impact of Diabetes and High-Deductible Health Plans
FDA-Cleared Devices: The Future of AI in Medical Imaging
Cost-effective Treatment: A Closer Look at SGLT2 Inhibitors
Machine Learning to Improve Diagnosis of Long QT Syndrome
Preventing Cardiovascular Disease: The Financial Implications
Artificial Intelligence in Predicting Cardiac Amyloidosis in TAVR
« Previous
1
…
4
5
6
7
8
9
Next »